跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NAD+ AAA - TGA Drug Approval Details
Approvals
/
TGA
/
NAD+ AAA
Approved
STANDARD
NAD+ AAA
Renhe Biotech (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Jul 2, 2025
Approval ID
a7b9c8e2bb493d9a
Company
Renhe Biotech (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
a7b9c8e2bb493d9a
Product Name
NAD+ AAA
Artg Id
495386
Artg Name
NAD+ AAA
Sponsor
Renhe Biotech (Australia) Pty Ltd
Company Detail Path
/organization/renhe-biotech-australia-pty-ltd
Artg Date
2025-06-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Jul 2, 2025
Approval ID
a7b9c8e2bb493d9a
Type
Standard
Back to TGA Approvals